Brain Cancer Trial, Recruiting NCT07224503 Sponsor: Virginia Commonwealth University Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07224503
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Patients:

  • People who receive care at the Virginia Commonwealth University Neuro-Oncology clinic
  • People who have a confirmed primary brain tumor diagnosis, either through a tissue sample (biopsy) or a specialist's review of brain scans
  • People who show reduced ability in at least one area of thinking or memory, based on specific cognitive tests used by the trial
  • People whose estimated baseline intellectual ability falls above a certain threshold, as measured by a standard test (confirm with trial site)
  • People who are at least one month past brain surgery and/or radiation therapy, if they had either of these treatments
  • People aged 18 or older
  • People who primarily speak English

Caregivers:

  • People who are enrolling alongside a patient who meets the criteria above
  • People aged 18 or older
  • People who primarily speak English

Who may not be able to join:

Patients:

  • People with severe thinking or memory difficulties that would prevent them from taking part, including severe difficulty with speech or language, or an inability to understand and agree to participate
  • People who are unable to attend weekly video appointments
  • People who have significant sleep problems that they find more disruptive than their thinking or memory difficulties
  • People who are less than one month past brain surgery and/or radiation therapy
  • People without a stable internet connection or ability to use video-calling software (note: the trial will provide a tablet device if a participant does not have a suitable one)
  • People who have metal in their body, as this could be unsafe during the MRI scan
  • People who are pregnant, as the MRI scan may carry risks to an unborn baby

Caregivers:

  • No specific exclusion criteria listed for caregivers (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah Braun, Ph.D, Virginia Commonwealth University

Phone: 804-628-7028

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assess the feasibility of the C-SMART and BE Well protocols in brain tumor patients- Eligibility Rate; Assess the feasibility of the C-SMART and BE Well protocols in brain tumor patients - Enrollment Rate; Assess the feasibility of the C-SMART and BE Well protocols in brain tumor patients -- retention rate; Assess the acceptability of the C-SMART and BE Well protocols in brain tumor patients -- intervention completion rate; Assess the acceptability of the C-SMART and BE Well protocols in brain tumor patients - Participant satisfaction ratings; Assess the acceptability of the C-SMART and BE Wel...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov